Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2341 to 2355 of 7710 results

  1. Digital technologies for assessing attention deficit hyperactivity disorder (ADHD) (DG60)

    Evidence-based recommendations on digital technologies for assessing attention deficit hyperactivity disorder (ADHD)

    Diagnostics guidance
    Published
    21 October 2024
    View recommendations

    Sections for DG60

  2. Heart failure algorithms for remote monitoring in people with cardiac implantable electronic devices (DG61)

    Evidence-based recommendations on CorVue (Abbott Medical), HeartInsight (Biotronik), HeartLogic (Boston Scientific) and TriageHF (Medtronic) for algorithm-based remote monitoring in people with cardiac implantable electronic devices

    Diagnostics guidance
    Published
    24 October 2024
    View recommendations

    Sections for DG61

  3. Cemiplimab with platinum-based chemotherapy for untreated advanced non-small-cell lung cancer [ID3949]

    In development [GID-TA10907] Expected publication date: 30 April 2025

    Technology appraisal guidance
    In development

  4. Noninvasive Vagus Nerve Stimulation For reactive airway disease

    Register an interest in this interventional procedure   ...

    Interventional procedures guidance
    Topic selection

  5. Osteoporosis: risk assessment, treatment, and fragility fracture prevention (update)

    In development [GID-NG10216] Expected publication date: TBC

    NICE guideline
    In development

  6. Biomarker tests to help diagnose preterm labour in women with intact membranes (DG33)

    Evidence-based recommendations on biomarker tests to help diagnose preterm labour in women with intact membranes. The tests are Actim Partus, PartoSure and the Rapid fetal fibronectin (fFN) 10Q Cassette Kit (at thresholds other than 50 nanograms/millilitre)

    Diagnostics guidance
    Published
    4 July 2018
    View recommendations

    Sections for DG33

  7. Dostarlimab with platinum-based chemotherapy for advanced or recurrent endometrial cancer with microsatellite stability or mismatch repair proficiency ID6415

    In development [GID-TA11503] Expected publication date: 10 September 2025

    Technology appraisal guidance
    In development

  8. Prolonged-release diazoxide choline for treating Prader-Willi syndrome [ID1389]

      Status ...

    Technology appraisal guidance
    Topic selection

  9. Seladelpar for previously treated primary biliary cholangitis ID6429

    In development [GID-TA11540] Expected publication date: 10 September 2025

    Technology appraisal guidance
    In development

  10. Vorasidenib for treating astrocytoma or oligodendroglioma with IDH1 or IDH2 mutations after surgery in people 12 years and over [ID6407]

    In development [GID-TA11498] Expected publication date: 10 September 2025

    Technology appraisal guidance
    In development

  11. Tofersen for treating amyotrophic lateral sclerosis caused by SOD1 gene mutations [ID3767]

    In development [GID-HST10062] Expected publication date: TBC

    Highly specialised technologies guidance
    In development

  12. Digital technologies to support smoking cessation in secondary care patients: early value assessment

    Awaiting development [GID-HTE10061] Expected publication date: TBC

    Health technology evaluations
    Awaiting development

  13. Artificial intelligence technologies for mammography: early value assessment

    Awaiting development [GID-HTE10062] Expected publication date: TBC

    Health technology evaluations
    Awaiting development

  14. Digital platforms to support self-management of asthma : early value assessment

    Awaiting development [GID-HTE10063] Expected publication date: TBC

    Health technology evaluations
    Awaiting development

  15. Dupilumab for treating severe chronic rhinosinusitis with nasal polyposis (Review of TA648) [ID6480]

    In development [GID-TA11630] Expected publication date: 11 September 2025

    Technology appraisal guidance
    In development